A common mitchondrial DNA variant is associated with thinness in mothers and their 20-yr-old offspring

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 6, 2005, Pages

  Parker, Ellen ^a   Phillips, D I W ^b   Cockington, Richard A ^c   Cull, Carole ^d   Poulton, Jo ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

16189 variant; 16189 16193 poly C tract; Birth weight; Mitochondrial deoxyribonucleic acid; OriB variant; Placenta

Indexed keywords

INSULIN; MITOCHONDRIAL DNA;

ADULT; ARTICLE; B LYMPHOCYTE; BIRTH WEIGHT; BODY MASS; BODY WEIGHT; CELL FUNCTION; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HAPLOTYPE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MOTHER; PRIORITY JOURNAL; PROGENY; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; AUSTRALIA; COMPARATIVE STUDY; GENETIC VARIABILITY; GENETICS; GLUCOSE TOLERANCE TEST; HISTOLOGY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN SIZE; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY;

ADULT; AUSTRALIA; BIRTH WEIGHT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DNA, MITOCHONDRIAL; FEMALE; GLUCOSE TOLERANCE TEST; HAPLOTYPES; HUMANS; MALE; MOTHERS; ORGAN SIZE; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; THINNESS; VARIATION (GENETICS);

EID: 33644663462     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00600.2004     Document Type: Article

References (40)

1. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, and Lander ES. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26: 76-80, 2000.
2. Ashcroft E and Ashcroft S. Mechanisms of insulin secretion. In: Insulin: Molecular Biology to Pathology, edited by Ashcroft F and Ashcroft S. Oxford, UK: Oxford Univ. Press, 1992, p. 97-150.
3. Barak YNM, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, and Evans RM. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4: 585-595, 1999.
4. Casteels K, Ong K, Phillips D, Bendall H, Pembrey M, The study team ALSPAC, Poulton J, and Dunger D. Mitochondrial 16189 variant, thinness at birth, and type-2 diabetes. ALSPAC study team. Avon Longitudinal Study of Pregnancy and Childhood. Lancet 353: 1499-1500, 1999.
5. Costanzo PR and Schiffman SS. Thinness-not obesity- has a genetic component. Neurosci Biobehav Rev 13: 55-58, 1989.
6. Evans RM, Barish GD, and Wang YX. PPARs and the complex journey to obesity. Nat Med 10: 355-361, 2004.
7. Flanagan DE, Moore VM, Godsland IF, Cockington RA, Robinson JS, and Phillips DI. Fetal growth and the physiological control of glucose tolerance in adults: a minimal model analysis. Am J Physiol Endocrinol Metab 278: E700-E706, 2000.
8. Godfrey K, Robinson S, Barker DJ, Osmond C, and Cox V. Maternal nutrition in early and late pregnancy in relation to placental and fetal growth. BMJ 312: 410-414, 1996.
9. Godfrey KM, Redman CW, Barker DJ, and Osmond C. The effect of maternal anaemia and iron deficiency on the ratio of fetal weight to placental weight. Br J Obstet Gynaecol 98: 886-891, 1991.
10. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, and Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 19: 268-270, 1998.
11. Keers SM, Gibson AM, Turnbull DM, and Chinnery PF. No evidence of an association between the mtDNA 16184-93 polyC tract and late onset dementia. J Med Genet 41: 957-958, 2004.
12. Kraytsberg Y, Schwartz M, Brown TA, Ebralidse K, Kunz WS, Clayton DA, Vissing J, and Khrapko K. Recombination of human mitochondrial DNA. Science 304: 981, 2004.
13. Lao TT and Wong WM. Placental ratio and intrauterine growth retardation. Br J Obstet Gynaecol 103: 924-926, 1996.
14. Leary SC and Shoubridge EA. Mitochondrial biogenesis: which part of "NO" do we understand? Bioessays 25: 538-541, 2003.
15. Little RE, Zadorozhnaja TD, Hulchiy OP, Mendel NA, Shkyryak-Nyzhnyk ZA, Chyslovska N, and Gladen BC. Placental weight and its ratio to birthweight in a Ukrainian city. Early Hum Dev 71: 117-127, 2003.
16. Masud S and Ye S. Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet 40: 773-780, 2003.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, and Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
18. Montague CT and O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49: 883-888, 2000.
19. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, and Groop LC. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273, 2003.
20. Morten K, Field P, Ashley N, Williams KA, Harris D, Hartley M, Clark A, and Poulton J. Fetal and neonatal exposure of mice to zidovudine (AZT) and low protein diet affects glucose homeostasis: implications for AIDS prevention. Am J Physiol Endocrinol Metab 289: 1115-1118, 2005.
21. Morten K, Jen C, and Poulton J. The 16189 variant of mtDNA in type 2 diabetes: towards a molecular mechanism (Abstract). Diabet Med 20, Suppl 2: 13, 2003.
22. Owens JA, Falconer J, and Robinson JS. Effect of restriction of placental growth on fetal and utero-placental metabolism. J Dev Physiol 9: 225-238, 1987.
23. Pace CS, Martin AM, Hammond EL, Mamotte CD, Nolan DA, and Mallal SA. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients. Antivir Ther 8: 323-331, 2003.
24. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, and Mandarino LJ. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100: 8466-8471, 2003.
25. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, and Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-1142, 2003.
26. Petersen KF, Dufour S, Befroy D, Garcia R, and Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671, 2004.
27. Poulton J and Das S. Correction: no evidence of an association between the T16189C mtDNA variant and late onset dementia (Gibson et al). J Med Genet 41: 957, 2004 [author reply p. 957-958].
28. Poulton J, Luan J, Macaulay V, Hennings S, Mitchell J, and Wareham NJ. Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case-control study. Hum Mol Genet 11: 1581-1583, 2002.
29. Poulton J, O'Rahilly S, Morten K, and Clark A. Mitochondrial DNA, diabetes and pancreatic pathology in Kearns-Sayre syndrome. Diabetologia 38: 868-871, 1995.
30. Poulton J, Scott-Brown M, Cooper A, Marchington D, and Phillips D. A common mitochondrial DNA variant is associated with insulin resistance in adult life. Diabetologia 41: 54-58, 1998.
31. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, and Trembath RC. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340: 1376-1379, 1992.
32. Richards MB, Macaulay VA, Bandelt HJ, and Sykes BC. Phylogeography of mitochondrial DNA in western Europe. Ann Hum Genet 62: 241-260, 1998.
33. Robinson J, Chidzanja S, Kind K, Lok F, Owens P, and Owens J. Placental control of fetal growth. Reprod Fertil Dev 7: 333-344, 1995.
34. Silva JP, Kohler M, Graff C, Oldfors A, Magnuson MA, Berggren PO, and Larsson NG. Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nat Genet 26: 336-340, 2000.
35. Soejima A, Inoue K, Takai D, Kaneko M, Ishihara H, Oka Y, and Hayashi J. Mitochondrial DNA is required for regulation of glucose-stimulated insulin secretion in a mouse pancreatic beta cell line; MIN6. J Biol Chem 271: 26194, 1996.
36. Sue CM, Holmes-Walker DJ, Morris JG, Boyages SC, Crimmins DS, and Byrne E. Mitochondrial gene mutations and diabetes mellitus [letter]. Lancet 341: 437-438, 1993.
37. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly YM, Gidlof S, Oldfors A, Wibom R, Tornell J, Jacobs HT, and Larsson NG. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417-423, 2004.
38. Vila MR, Gamez J, Solano A, Playan A, Schwartz S, Santorelli FM, Cervera C, Casali C, Montoya J, and Villarroya F. Uncoupling protein-1 mRNA expression in lipomas from patients bearing pathogenic mitochondrial DNA mutations. Biochem Biophys Res Commun 278: 800-802, 2000.
39. Welsh N, Paabo S, and Welsh M. Decreased mitochondrial gene expression in isolated islets of rats injected neonatally with streptozotocin. Diabetologia 34: 626-631, 1991.
40. Yakusawa T, Yang M, Jacobs H, and Holt I. A bidirectional origin of replication maps to the major non-coding region of human mitochondrial DNA. Mol Cell 18: 651-662, 2005.